Pablo focuses on biotechnology and healthcare ventures. Previously, Pablo was an Investment Manager at Midven, a UK based early-stage biotech fund, and worked in Corporate Development at the cell and gene editing company Horizon Discovery.
He holds degrees in Neuropharmacology and Biochemical Engineering from University College London and an MPhil in Bioscience Enterprise from the University of Cambridge.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557